VulnerabilityModified
CVE-2022-30277
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability.
MEDIUM 5.7EPSS 0.22%
Does this matter?
Lower severity and a low EPSS score (0.22%). Track it; it rarely justifies an emergency change on its own.
Description
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
- CVSS 3.1
- 5.7 MEDIUMCVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
- EPSS
- 0.22% probability · 13th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-613
- Affected
- bd/synapsys
- Source
- cybersecurity@bd.com
References
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.